Last reviewed · How we verify
NCT06550817
Growth Mindset Intervention for Older Adults With Chronic Disease
NA trial testing Growth mindset intervention in Chronic Disease in 77 participants. Completed in 31 October 2022.
31 October 2022
Quick facts
| Lead sponsor | Huzhou University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 77 |
| Start date | 1 September 2021 |
| Primary completion | 31 October 2022 |
| Estimated completion | 31 October 2022 |
| Sites | 2 locations across China |
Drugs / interventions tested
- Growth mindset intervention
- E-health Program
Conditions studied
- Chronic Disease — all drugs for Chronic Disease →
Sponsor
Huzhou University
Who can join
60 and older, any sex, with Chronic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to develop and investigate the effectiveness of a growth mindset intervention based on growth mindset theory.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Growth Mindset Intervention's Impact on Positive Response to eHealth for Older Adults With Chronic Disease: Randomized Controlled Trial.
Cao M, Xu X, Zeng Y, Zhao B, et al · · 2025 · cited 1× · PMID 40638358 · DOI 10.2196/65519
Verify or expand the search:
- PubMed search for NCT06550817
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Disease
Currently open trials in the same condition.
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07375550 — Determinants of Medication Non-Adherence Among Patients With Chronic Diseases in Egyptian Community Pharmacies · recruiting
- NCT07120464 — Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations · recruiting
Other Huzhou University trials
Trials by the same sponsor.
- NCT07160803 — Migrant Elderly's Social Network Use Intervention: An Activity Theory-Based Study · NA · completed
- NCT07040371 — Health Promotion Behavior Intervention for Elderly Migrants to Improve Health Outcomes · NA · completed
- NCT07105774 — The Effects of Stress Inoculation Training Program on Occupational Stress Level, Coping Style, and Sleep Quality in New · NA · completed
- NCT06508528 — Intervention of Growth Mindset for Intern Nursing Students · NA · completed
- NCT06615219 — Intergroup Contact Intervention for Nursing Undergraduates to Improve Aging Stereotype · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06550817 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Huzhou University
- Last refreshed: 13 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06550817.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing